Insights
webinar
Scale-up and Production of Key lipids used in mRNA Delivery Systems
This webinar will explore the specific requirements for industrializing processes in the production of ionizable lipids and PEG lipids, elucidating concepts to address typical challenges.
webinar
From Conception to Manufacturing. Accelerating Therapies with Curia
In this podcast, we will explore the advantages of partnering with a Contract Development and Manufacturing Organization (CDMO) to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness...
webinar
Customized mRNA Processing for Improved Therapy Development and Manufacturing
In this GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.
article
Trends and Challenges in the Pharmaceutical Industry
Significant changes have taken place in the life sciences industry over the past few years. Since the Covid-19 pandemic, the U.S. government has urged biotech and pharmaceutical companies to increase domestic production in order to secure the drug su...
webinar
Fast-Tracking Drug Development and Scale-Up in the Post-Covid World
The webinar focuses on truncating drug development timelines in the aftermath of COVID-19. The featured speaker emphasizes phase-appropriate development, offering creative solutions and round-the-clock development across various continents.
webinar
RNA Vaccines: Quality Concepts in GMP IVT mRNA Development, Manufacturing & Analytics
This webinar will provide a general overview of mRNA therapeutics design and production and discuss the importance of robust quality systems in the context of GMP production of mRNA therapeutics.
white paper
The current and future value of mRNA vaccines and therapeutics
With experience in both chemistry and biologics, Curia is uniquely positioned to provide mRNA drug development solutions spanning discovery and engineering, mRNA drug substance formulation, and fill-finish and manufacturing of lipids and nucleosides.
white paper
Accelerated API manufacturing by combining early-stage and late-stage process development
Traditionally, early-stage and late-stage process development have been done separately, with early-stage mostly focused on material production and late-stage on process intensification. As more molecules in development fall under an orphan or fast-t...